BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

975 related articles for article (PubMed ID: 15189148)

  • 21. A model for step-wise assembly of heterochromatin in yeast.
    Moazed D; Rudner AD; Huang J; Hoppe GJ; Tanny JC
    Novartis Found Symp; 2004; 259():48-56; discussion 56-62, 163-9. PubMed ID: 15171246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases.
    Marmorstein R
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):904-9. PubMed ID: 15506920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.
    Sauve AA; Schramm VL
    Biochemistry; 2003 Aug; 42(31):9249-56. PubMed ID: 12899610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of conditional alleles of the yeast SIR2 gene.
    Hickman M; McCullough K; Woike A; Raducha-Grace L; Rozario T; Dula ML; Anderson E; Margalit D; Holmes SG
    J Mol Biol; 2007 Apr; 367(5):1246-57. PubMed ID: 17316680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A yeast sir2 mutant temperature sensitive for silencing.
    Wang CL; Landry J; Sternglanz R
    Genetics; 2008 Dec; 180(4):1955-62. PubMed ID: 18845844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of Sir2 inhibitors through phenotypic assays in yeast.
    Posakony J; Hirao M; Bedalov A
    Comb Chem High Throughput Screen; 2004 Nov; 7(7):661-8. PubMed ID: 15578928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A unique class of conditional sir2 mutants displays distinct silencing defects in Saccharomyces cerevisiae.
    Garcia SN; Pillus L
    Genetics; 2002 Oct; 162(2):721-36. PubMed ID: 12399383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The NAD(+)-dependent Sir2p histone deacetylase is a negative regulator of chromosomal DNA replication.
    Pappas DL; Frisch R; Weinreich M
    Genes Dev; 2004 Apr; 18(7):769-81. PubMed ID: 15082529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reconstitution of yeast silent chromatin: multiple contact sites and O-AADPR binding load SIR complexes onto nucleosomes in vitro.
    Martino F; Kueng S; Robinson P; Tsai-Pflugfelder M; van Leeuwen F; Ziegler M; Cubizolles F; Cockell MM; Rhodes D; Gasser SM
    Mol Cell; 2009 Feb; 33(3):323-34. PubMed ID: 19217406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assays for characterization of the Sir2 family of NAD(+)-dependent deacetylases.
    Borra MT; Denu JM
    Methods Enzymol; 2004; 376():171-87. PubMed ID: 14975305
    [No Abstract]   [Full Text] [Related]  

  • 31. Limiting the extent of the RDN1 heterochromatin domain by a silencing barrier and Sir2 protein levels in Saccharomyces cerevisiae.
    Biswas M; Maqani N; Rai R; Kumaran SP; Iyer KR; Sendinc E; Smith JS; Laloraya S
    Mol Cell Biol; 2009 May; 29(10):2889-98. PubMed ID: 19289503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in Saccharomyces cerevisiae gene SIR2 can have differential effects on in vivo silencing phenotypes and in vitro histone deacetylation activity.
    Armstrong CM; Kaeberlein M; Imai SI; Guarente L
    Mol Biol Cell; 2002 Apr; 13(4):1427-38. PubMed ID: 11950950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition.
    Sauve AA; Moir RD; Schramm VL; Willis IM
    Mol Cell; 2005 Feb; 17(4):595-601. PubMed ID: 15721262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enforcement of a lifespan-sustaining distribution of Sir2 between telomeres, mating-type loci, and rDNA repeats by Rif1.
    Salvi JS; Chan JN; Pettigrew C; Liu TT; Wu JD; Mekhail K
    Aging Cell; 2013 Feb; 12(1):67-75. PubMed ID: 23082874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silent information regulator protein complexes in Saccharomyces cerevisiae: a SIR2/SIR4 complex and evidence for a regulatory domain in SIR4 that inhibits its interaction with SIR3.
    Moazed D; Kistler A; Axelrod A; Rine J; Johnson AD
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2186-91. PubMed ID: 9122169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the histone deacetylase SIRT2.
    Finnin MS; Donigian JR; Pavletich NP
    Nat Struct Biol; 2001 Jul; 8(7):621-5. PubMed ID: 11427894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rpd3-dependent boundary formation at telomeres by removal of Sir2 substrate.
    Ehrentraut S; Weber JM; Dybowski JN; Hoffmann D; Ehrenhofer-Murray AE
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5522-7. PubMed ID: 20133733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a human gene with sequence homology to Saccharomyces cerevisiae SIR2.
    Afshar G; Murnane JP
    Gene; 1999 Jun; 234(1):161-8. PubMed ID: 10393250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SIR2 family of NAD(+)-dependent protein deacetylases.
    Smith JS; Avalos J; Celic I; Muhammad S; Wolberger C; Boeke JD
    Methods Enzymol; 2002; 353():282-300. PubMed ID: 12078503
    [No Abstract]   [Full Text] [Related]  

  • 40. SIR2-induced inviability is suppressed by histone H4 overexpression.
    Matecic M; Stuart S; Holmes SG
    Genetics; 2002 Oct; 162(2):973-6. PubMed ID: 12399404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.